Hcp, Inc. (HCP) Files Form 4 Insider Selling : Kai Hsiao Sells 266 Shares

Hcp, Inc. (HCP): Kai Hsiao , Executive Vice President of Hcp, Inc. sold 266 shares on May 9, 2016. The Insider selling transaction was reported by the company on May 11, 2016 to the Securities and Exchange Commission. The shares were sold at $36.04 per share for a total value of $9,586.64 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 17, 2016, John D. Stasinos (Executive Vice President) purchased 400 shares at $26.24 per share price.On Feb 16, 2016, Troy E. Mchenry (EVP, Gen Counsel and Corp Sec) purchased 1,000 shares at $25.75 per share price.Also, On Feb 16, 2016, Thomas D Kirby (Executive Vice President) purchased 500 shares at $26.10 per share price.On Feb 12, 2016, Lihpang Lu (Executive Vice President) purchased 1,000 shares at $26.61 per share price.

Shares of HCP (HCP) ended Tuesday, May 10, 2016 session in red amid volatile trading. The shares closed down -1.28 points or -3.56% at $34.71 with 1,03,69,294 shares getting traded. Post opening the session at $36.23, the shares hit an intraday low of $34.08 and an intraday high of $36.39 and the price vacillated in this range throughout the day. The company has a market cap of $16,213 M and the number of outstanding shares has been calculated to be 46,70,87,590 shares. The 52-week high of HCP is $40.9 and the 52-week low is $25.1104.

HCP Money Flow Index Chart

Company has been under the radar of several Street Analysts.HCP is Upgraded by Jefferies to Hold. Earlier the firm had a rating of Underperform on the company shares. The Rating was issued on May 10, 2016.HCP is Downgraded by UBS to Neutral and the brokerage firm has set the Price Target at $31. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Mar 16, 2016.HCP is Reiterated by Barclays to Underweight while Lowering the Price Target of the company shares to $ 33 from a previous price target of $37 . The Rating was issued on Mar 10, 2016.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.